THE INVESTOR

메뉴열기
December 09, 2019

Samsung Biologics receives ISO certification

PUBLISHED : November 14, 2019 - 16:23

UPDATED : November 14, 2019 - 16:23

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • 트위터
  • sms

Samsung Biologics announced Nov. 14 that it has received 27001 security certification from the Geneva-based International Organization for Standardization.

The company emphasized that it is the first contract manufacturing organization to obtain ISO 27001 certification.

 

Samsung Biologics CEO Kim Tae-han(left) and German Ambassador to South Korea Stephan Auer



German Ambassador to South Korea Stephan Auer awarded the certification on behalf of DQS, a Germany-based global institute with the authority to certify the effectiveness of companies’ information security management systems.

DQS examined the company’s security systems for four months, considering 114 criteria across 14 categories.

“The qualities that are required to receive ISO 27001 certification are very similar to the requirements that our clients expect of CMOs. Now that we have this certification, our global clients can have more trust in our security systems,” Samsung Biologics official Kim Yong-shin said in a statement. He also added that the company expected to gain more clients as a result.

According to the company, acquiring certification is a significant step because a CMO business has to deal with sensitive information about its clients when developing products for them. This information is usually related to the clients’ core competencies.

By Song Seung-hyun (ssh@heraldcorp.com)

  • 페이스북
  • 트위터
  • sms
최상단으로
Herald Corporation|CEO : Kwon Chung Won
Publisher. Editor : Kwon Chung Won
Chief Privacy Officer & Juvenile Protection Manager : Yang Sung-jin
Title : The Investor|Date of registration : 2015.04.28
Company Registration No. 104-81-06004
Mail-Order Business Registration 2016 - Seoul Yongsan - 00590
Huam-ro 4-gil 10, Yongsan-gu, Seoul, Korea
T : +82-2-727-0114|Business info
Gov’t registration No. Seoul 아04099
COPYRIGHT HERALD CORPORATION. ALL RIGHTS RESERVED.